Cancer immunotherapy with chemoattractant peptides
- 1 June 2004
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 14 (3), 209-218
- https://doi.org/10.1016/j.semcancer.2003.10.008
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Inflammation and cancerNature, 2002
- Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2Science, 2002
- Lymphotactin cotransfection enhances the therapeutic efficacy of dendritic cells genetically modified with melanoma antigen gp100Gene Therapy, 2002
- Chemokines: agents for the immunotherapy of cancer?Nature Reviews Immunology, 2002
- Identification of a novel, multifunctional *-defensin (human *-defensin 3) with specific antimicrobial activityCell and tissue research, 2001
- Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in VivoThe Journal of Experimental Medicine, 2001
- Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activityThe FASEB Journal, 2001
- Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1Nature, 2000
- The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cellsEuropean Journal of Immunology, 1997
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990